Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

371 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Oral vs intravenous tacrolimus-based induction therapy in renal transplantation.
Tojimbara T, Kimikawa M, Nakajima I, Sato S, Nakamura M, Ishida H, Tanabe K, Koyama I, Utsumi K, Sannomiya A, Tsuji K, Fuchinoue S, Agishi T. Tojimbara T, et al. Among authors: koyama i. Transplant Proc. 1999 Nov;31(7):2763-4. doi: 10.1016/s0041-1345(99)00558-8. Transplant Proc. 1999. PMID: 10578282 Clinical Trial. No abstract available.
Clinical utility of monitoring sialyl Lewis(X) (CD15S) antigen on peripheral lymphocytes for the diagnosis and treatment of rejection after renal transplantation.
Ishida H, Koyama I, Sawada T, Murakami T, Utsumi K, Sannomiya A, Tsuji K, Tojimbara T, Nakajima I, Tanabe K, Fuchinoue S, Yamaguchi Y, Toma H, Agishi T. Ishida H, et al. Among authors: koyama i. Transplantation. 2000 Jan 15;69(1):59-63. doi: 10.1097/00007890-200001150-00012. Transplantation. 2000. PMID: 10653381
Clinical utility of monitoring sialyl Lewis(x) (CD15s) antigen on peripheral lymphocytes for the diagnosis and treatment of rejection after renal transplantation.
Ishida H, Koyama I, Sawada T, Murakami T, Utsumi K, Sannomiya A, Tsuji K, Tojimbara T, Nakajima I, Tanabe K, Fuchinoue S, Yamaguchi Y, Toma H, Agishi T. Ishida H, et al. Among authors: koyama i. Transplant Proc. 2000 Mar;32(2):265-8. doi: 10.1016/s0041-1345(99)00952-5. Transplant Proc. 2000. PMID: 10715412 No abstract available.
Sialyl Lewis(x) (CD15s) monitoring as a means to select antirejection therapy in patients with rejection after renal transplantation: CD15s monitoring for treatment and diagnosis in patients with acute rejection after renal transplantation.
Ishida H, Koyama I, Sawada T, Murakami T, Tojimbara T, Nakajima I, Tanabe K, Yamaguchi Y, Fuchinoue S, Toma H, Agishi T. Ishida H, et al. Among authors: koyama i. Transplantation. 2000 May 27;69(10):2208-11. doi: 10.1097/00007890-200005270-00046. Transplantation. 2000. PMID: 10852628
Anti-AB titer changes in patients with ABO incompatibility after living related kidney transplantations: survey of 101 cases to determine whether splenectomies are necessary for successful transplantation.
Ishida H, Koyama I, Sawada T, Utsumi K, Murakami T, Sannomiya A, Tsuji K, Yoshimura N, Tojimbara T, Nakajima I, Tanabe K, Yamaguchi Y, Fuchinoue S, Takahashi K, Teraoka S, Ito K, Toma H, Agishi T. Ishida H, et al. Among authors: koyama i. Transplantation. 2000 Aug 27;70(4):681-5. doi: 10.1097/00007890-200008270-00024. Transplantation. 2000. PMID: 10972229
Comparative study of clinical outcome in kidney transplantation between early steroid withdrawal protocol using basiliximab, calcineurin inhibitor, and mycophenolate mofetil and triple regimen consisting of calcineurin inhibitor, mycophenolate mofetil, and steroid.
Teraoka S, Sato S, Sekijima M, Iwado K, Urashima Y, Kudo S, Kai K, Koyama I, Tojinbara T, Nakajima I, Fuchinoue S. Teraoka S, et al. Among authors: koyama i. Transplant Proc. 2005 Mar;37(2):791-4. doi: 10.1016/j.transproceed.2004.12.185. Transplant Proc. 2005. PMID: 15848533 Clinical Trial.
371 results